In 2018, the global Infectious Disease Diagnostic Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Infectious Disease Diagnostic Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Diagnostic Testing development in United States, Europe and China.
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-infectious-disease-diagnostic-testing-2019-2025-781
The key players covered in this study
- Abbott
- Alere
- bioMerieux
- Diasorin
- Roche Diagnostic
- BD
- Gold Standard Diagnostics
- Hologic
- Siemens Healthcare Diagnostics
- TECHLAB
- Bio-Rad Laboratories
- Corgenix
- Cepheid
- Meridian Bioscience
Market segment by Type, the product can be split into
- Molecular Diagnostic Test
- POC Infectious Disease Diagnostics Test
Market segment by Application, split into
- HIV
- HAIs
- Respiratory
- Tropical Diseases
- Liver
- Other
Market segment by Regions/Countries, this report covers
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
The study objectives of this report are:
- To analyze global Infectious Disease Diagnostic Testing status, future forecast, growth opportunity, key market and key players.
- To present the Infectious Disease Diagnostic Testing development in United States, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Infectious Disease Diagnostic Testing are as follows:
- History Year: 2014-2018
- Base Year: 2018
- Estimated Year: 2019
- Forecast Year 2019 to 2025
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: help@24marketreports.com
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Market growth is driven by the global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements.
[263 Pages Report] The global infectious disease diagnostics market size is projected to reach USD 39.8 billion by 2026 from USD 28.1 billion in 2021, at a CAGR of 7.2%.This study involved four major activities in estimating the current size of the infectious disease diagnostics market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Market DynamicsGlobal prevalence of infectious diseases and onset of COVID-19Rising focus on R and funding in infectious disease diagnosticsGrowing awareness for early disease diagnosis in developing countriesRising technological advancements in infectious disease diagnosticsShift in focus from centralized laboratories to decentralized POC testingCOVID-19 Impact on Global Infectious Disease Diagnostics MarketCOVID-19 is an infectious disease caused by the most recently discovered novel coronavirus.
The COVID-19 pandemic negatively affected the overall sales of most of the companies but had an positive impact on the infectious disease diagnostics market because of the use of infectious disease diagnostic methods for COVID-19 testing.
Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589Based on product & service, the infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services.
In 2020, the reagents, kits, and consumables segment accounted for the largest share of this market.
The global Infectious Disease Rapid Diagnostic Testing Market is forecasted to be worth USD 3.56 Billion by 2027, according to a current analysis by Emergen Research.
The evolving pathogens and rise in the occurrence of hospital-acquired infections (HAIs) are creating a need for a quick diagnosis of the diseases to stop the spread.
The report includes profiles of major players in the Infectious Disease Rapid Diagnostic Testing market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/269The advancement in technology has also encouraged the infectious disease rapid diagnostic testing market growth.
However, the lack of proper reimbursement rates may result in lower access for patients to testing, which hinders market growth.
Global Infectious Disease Rapid Diagnostic Testing market revenue growth is supported to a significant extent due to rising focus by major players on product/service expansion into new and untapped domestic markets and rising competition in the market.
These factors are expected to drive incline in regional Infectious Disease Rapid Diagnostic Testing market share growth over the forecast period.Top key vendors in Infectious Disease Rapid Diagnostic Testing Market include are:Abbott Laboratories, Danaher Corporation, BGI Group, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Luminex Corporation, bioMérieux S.A., Hologic, Inc., Thermo Fisher Scientific Inc., and Becton, Dickinson, and Company, among others.Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/infectious-disease-rapid-diagnostic-testing-marketKey Highlights From The ReportBio-Rad Laboratories, in February 2020, acquired Exact Diagnostics of Fort Worth.
With developing technological innovations in the health care sector comprising biosensors, smartphone apps, lab-on-chip and tech tops, that offer a nearer association with the patient.
The main reason that this type of testing is trending nowadays is because of its access and quicker results.
Decentralized infectious testing lets faster clinical decisions at the physician’s clinic, ambulance, and home.
As this testing system is portable and moving it to the site of the patient, increases the chances of the physician, patient and the care team to have faster results and immediate decision making.
The decentralized testing market has professional and patient friendly or self-monitored testing like food pathogens, hematology, infectious diseases, coagulation test and urine analysis.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=14177 The factors driving the trend of decentralized infectious disease testing include increasing trend of patient centric care, technological innovations, shortage of laboratory staff, increasing aging population, and rising incidences of infectious diseases.
